Xiangyu Medical
68862642.805.52% ( +2.24 )
Xiangyu Medical (688626)
Xiangyu Medical Co.,Ltd engages in the research, development, manufacture, and marketing of rehabilitation, physiotherapy, and pain management equipment in Chin...
- Open
- 40.05
- High
- 43.13
- Low
- 40.05
- Prev. Close
- 40.56
- Volume
- 32.21K
- Turnover
- 136.23M
- Avg Price
- 42.29
- Bid/Ask Ratio
- --
- Amplitude
- 7.59%
- 52wk High
- 94.82
- Volume Ratio
- 0.94
- Turnover Ratio
- 2.01%
Xiangyu Medical Analyst Rating
View MoreForecast & Rating
Jun 9, 2026Price forecast
¥58.0035.51%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Wallstreetcn · Apr 9 at 05:32 PM
Enterprises Step Up Deployment, Commercialization of Brain-Computer Interfaces Accelerates
- CoinLive · Apr 5 at 07:34 PM
AI TRENDS | Brain-Computer Interface Technology Set for Commercial Expansion by 2026
- 36Kr · Mar 23 at 06:57 PM
Brain-computer interfaces are becoming a reality, with over 100 institutions researching 5 concept stocks this year
- Wallstreetcn · Feb 13 at 12:14 AM
The A-share brain-computer interface concept is actively defying the trend, with BIOTEST BIOTECH rising over 10%, and Meihao Medical, Sanbo, APON, and Xiangyu Medical following suit
- 36Kr · Jan 4 at 09:36 PM
The three major A-share indices collectively rose at the midday break, with the brain-computer interface concept triggering a surge in limit-up stocks
- Wallstreetcn · Jan 4 at 07:27 PM
The concept of brain-computer interfaces opened with a significant surge, with multiple stocks including Sanbo Neuroscience, MeHow, Stonehill Technology, Innovative Medical, and NANJING PANDA hitting the daily limit up. Xiangyu Medical and APON rose over 10%
